Home
Conditions
Malignant Ascites

Clinical trial condition

Malignant Ascites

Explore clinical trials studying Malignant Ascites. Study availability and eligibility vary by location and protocol.

23 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Malignant Ascites trial results

Recruiting

Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases

NCT05477927

Conditions: Central Nervous System Neoplasms, Leptomeningeal Metastases, Malignant Ascites, +8 more
Locations: West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Recruiting

Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy

NCT07397819

Conditions: Malignant Ascites
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Phase I Study of SIM0388 in Participants With Malignant Ascites.

NCT07007988

Conditions: Malignant Ascites
Locations: Shanghai Gobroad Cancer Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer

NCT06016179

Conditions: Malignant Ascites, Malignant Pleural Effusion, Neoplasms, +8 more
Locations: Allegheny Health Network Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Not yet recruiting

TLR9 Immunotherapy for Peritoneal Carcinomatosis

NCT07658196

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +18 more
Locations: Rhode Island and the Miriam Hospitals (Brown University Health) Providence, Rhode Island, United States

View Trial Details

Not yet recruiting

At-Home Paracentesis for Cancer-Related Malignant Ascites (Paracentesis)

NCT07490626

Conditions: Malignant Ascites
Locations: Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Not yet recruiting

NK521 in the Treatment of Advanced Solid Tumors

NCT07657416

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
Locations: 1st affiliated hospital of Anhui Medical University Hefei, Anhui, China

View Trial Details

Not yet recruiting

WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

NCT07615894

Conditions: Advanced Solid Tumors, Malignant Ascites, Malignant Pleural Effusions, +9 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Enrolling by invitation

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

NCT05745233

Conditions: Malignant Ascites
Locations: China Medical University Hospital Taichung, Please Select, Taiwan

View Trial Details

Active, not recruiting

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

NCT06432296

Conditions: Malignant Ascites
Locations: The First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Malignant Ascites

Malignant Ascites trial results

Related conditions